Is AbbVie Inc. Stock About to Crash?
AbbVie has been an amazing growth story since its inception in 2013. However, this trend might be about to come to abrupt end. Here's why.
The Single Worst Practice of the Drug Industry
Pay for delay is a legal maneuver Big Pharma uses to keep generic drugs off the market. According to the FTC, it costs consumers and taxpayers $3.5 billion every year.